• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非选择性β受体阻滞剂用于两名女婴特殊部位溃疡性婴儿血管瘤的有效治疗

Nonselective Beta-Blockers for the Efficacious Healing of Ulcerated Infantile Hemangiomas in Unusual Locations of Two Female Infants.

作者信息

Poulose Divya, Lote Samruddhi, Mahajan Aditi, Gogineni Jaya Madhurya

机构信息

Dermatology, Dr. D.Y. Patil Medical College Hospital and Research Centre, Pune, IND.

Dermatology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, IND.

出版信息

Cureus. 2021 Jul 28;13(7):e16683. doi: 10.7759/cureus.16683. eCollection 2021 Jul.

DOI:10.7759/cureus.16683
PMID:34462702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8389862/
Abstract

Infantile hemangiomas (IHs) are the most common vascular soft-tissue tumors of newborns and early childhood with a prevalence rate of approximately 4%-5% in infancy. Most of the IHs regress spontaneously after initial proliferation. Ulceration is one of the most common complications seen in IHs, which heal poorly without treatment. The prevalence of IHs is three times more in females compared to males. The most common location of IH is head and neck with the least being in extremities Oral propranolol and systemic corticosteroids are used as first-line therapy in the treatment. Topical timolol has been used as an alternative to counteract the long-term side effects of the prior modalities. In this study, we are reporting and presenting case reports of two female infants with ulcerated IH who were treated with oral propranolol and topical timolol, respectively, and comparing the efficacy of one over the other. we observed fast and efficacious healing with oral propranolol when used with proper monitoring, as compared to topical timolol, although the latter is more commonly used as it is safer with fewer potential side effects.

摘要

婴儿血管瘤(IHs)是新生儿和幼儿期最常见的血管软组织肿瘤,在婴儿期的患病率约为4%-5%。大多数婴儿血管瘤在最初增殖后会自发消退。溃疡是婴儿血管瘤最常见的并发症之一,未经治疗很难愈合。婴儿血管瘤的患病率女性是男性的三倍。婴儿血管瘤最常见的部位是头颈部,四肢最少见。口服普萘洛尔和全身用糖皮质激素被用作治疗的一线疗法。局部用噻吗洛尔已被用作替代疗法,以对抗先前治疗方式的长期副作用。在本研究中,我们报告并展示了两名患有溃疡型婴儿血管瘤的女婴的病例报告,她们分别接受了口服普萘洛尔和局部用噻吗洛尔治疗,并比较了两者的疗效。我们观察到,与局部用噻吗洛尔相比,口服普萘洛尔在适当监测下使用时愈合迅速且有效,尽管后者因更安全、潜在副作用更少而更常用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c2/8389862/38147e9979b1/cureus-0013-00000016683-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c2/8389862/a814585197a0/cureus-0013-00000016683-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c2/8389862/38147e9979b1/cureus-0013-00000016683-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c2/8389862/a814585197a0/cureus-0013-00000016683-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c2/8389862/38147e9979b1/cureus-0013-00000016683-i02.jpg

相似文献

1
Nonselective Beta-Blockers for the Efficacious Healing of Ulcerated Infantile Hemangiomas in Unusual Locations of Two Female Infants.非选择性β受体阻滞剂用于两名女婴特殊部位溃疡性婴儿血管瘤的有效治疗
Cureus. 2021 Jul 28;13(7):e16683. doi: 10.7759/cureus.16683. eCollection 2021 Jul.
2
Efficacious Healing of Ulcerated Infantile Hemangiomas Using Topical Timolol.局部使用噻吗洛尔有效治愈溃疡性婴儿血管瘤。
Plast Reconstr Surg Glob Open. 2016 Feb 16;4(2):e621. doi: 10.1097/GOX.0000000000000605. eCollection 2016 Feb.
3
Efficacy and Safety of Oral Propranolol or Topical Timolol for the Treatment of Superficial Infantile Hemangiomas.口服普萘洛尔或局部用噻吗洛尔治疗浅表性婴幼儿血管瘤的疗效与安全性。
J Craniofac Surg. 2024 Feb 12. doi: 10.1097/SCS.0000000000010001.
4
Infantile hemangiomas, complications and treatments.婴儿血管瘤、并发症及治疗
Semin Cutan Med Surg. 2016 Sep;35(3):108-16. doi: 10.12788/j.sder.2016.050.
5
Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas.局部用噻吗洛尔与口服普萘洛尔治疗浅表性婴儿血管瘤的对比研究
Front Oncol. 2018 Dec 18;8:605. doi: 10.3389/fonc.2018.00605. eCollection 2018.
6
Efficiency of Topical Beta-Blockers for Epistaxis Control in Ulcerated Infantile Hemangioma.外用β受体阻滞剂控制溃疡性婴儿血管瘤鼻出血的疗效
Cureus. 2024 Aug 25;16(8):e67709. doi: 10.7759/cureus.67709. eCollection 2024 Aug.
7
Propranolol therapy for infantile hemangioma: our experience.普萘洛尔治疗婴儿血管瘤:我们的经验。
Drug Des Devel Ther. 2017 May 8;11:1401-1408. doi: 10.2147/DDDT.S134808. eCollection 2017.
8
Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.口服普萘洛尔和局部用噻吗洛尔治疗婴儿血管瘤的门诊应用:调查结果及与普萘洛尔共识声明指南的比较
Pediatr Dermatol. 2015 Mar-Apr;32(2):171-9. doi: 10.1111/pde.12435. Epub 2014 Dec 29.
9
Update on Treatment of Infantile Hemangiomas: What's New in the Last Five Years?婴儿血管瘤治疗的最新进展:过去五年有哪些新变化?
Front Pharmacol. 2022 May 26;13:879602. doi: 10.3389/fphar.2022.879602. eCollection 2022.
10
Topical Timolol for Infantile Haemangioma of the Orbit.眶部婴儿血管瘤的局部用噻吗洛尔。
Klin Monbl Augenheilkd. 2021 Oct;238(10):1069-1076. doi: 10.1055/a-1645-1665. Epub 2021 Oct 18.

本文引用的文献

1
Efficacious Healing of Ulcerated Infantile Hemangiomas Using Topical Timolol.局部使用噻吗洛尔有效治愈溃疡性婴儿血管瘤。
Plast Reconstr Surg Glob Open. 2016 Feb 16;4(2):e621. doi: 10.1097/GOX.0000000000000605. eCollection 2016 Feb.
2
Maternal and perinatal risk factors for infantile hemangioma: a case-control study.婴儿血管瘤的母婴及围产期危险因素:一项病例对照研究。
Pediatr Dermatol. 2013 Jul-Aug;30(4):457-61. doi: 10.1111/pde.12042. Epub 2012 Dec 26.
3
A randomized controlled trial of propranolol for infantile hemangiomas.
普萘洛尔治疗婴儿血管瘤的随机对照试验。
Pediatrics. 2011 Aug;128(2):e259-66. doi: 10.1542/peds.2010-0029. Epub 2011 Jul 25.
4
Propranolol for treatment of ulcerated infantile hemangiomas.普萘洛尔治疗溃疡性婴幼儿血管瘤。
J Am Acad Dermatol. 2011 May;64(5):827-32. doi: 10.1016/j.jaad.2010.12.040. Epub 2011 Feb 25.
5
Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution.增殖期婴儿血管瘤中肾素-血管紧张素系统成分的表达可能是普萘洛尔诱导其快速消退的原因。
J Plast Reconstr Aesthet Surg. 2011 Jun;64(6):759-65. doi: 10.1016/j.bjps.2010.08.039. Epub 2010 Sep 26.
6
Growth characteristics of infantile hemangiomas: implications for management.婴儿血管瘤的生长特征:对治疗的启示
Pediatrics. 2008 Aug;122(2):360-7. doi: 10.1542/peds.2007-2767.
7
Infantile hemangiomas: how common are they? A systematic review of the medical literature.婴儿血管瘤:它们有多常见?对医学文献的系统综述。
Pediatr Dermatol. 2008 Mar-Apr;25(2):168-73. doi: 10.1111/j.1525-1470.2008.00626.x.
8
Abortive or minimal-growth hemangiomas: Immunohistochemical evidence that they represent true infantile hemangiomas.消退期或微小生长型血管瘤:免疫组化证据表明它们代表真正的婴儿血管瘤。
J Am Acad Dermatol. 2008 Apr;58(4):685-90. doi: 10.1016/j.jaad.2007.08.007.
9
PELVIS Syndrome.骨盆综合征
Arch Dermatol. 2006 Jul;142(7):884-8. doi: 10.1001/archderm.142.7.884.
10
Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex.婴儿血管瘤:临床特征、形态学亚型及其与种族、民族和性别的关系。
Arch Dermatol. 2002 Dec;138(12):1567-76. doi: 10.1001/archderm.138.12.1567.